Not found

Keith A. Youker, PhD

Assistant Research Professor of Cardiovascular Sciences, Institute for Academic Medicine
Assistant Research Member, Research Institute
Houston Methodist


Biography

Dr. Keith Youker earned his Ph.D. in Cardiovascular Sciences from Baylor College of Medicine and was the first graduate from this program. The program initially used a broad knowledge approach to training including course work from medical school, graduate school, and cardiovascular core courses designed for basic scientists to work in clinical cardiovascular research. His dissertation work earned him a nomination for the Sigma Xi “Excellence in Science Dissertation Award”. Since graduation, Dr. Youker has been a faculty member in both the departments of Medicine and Surgery at Baylor College of Medicine prior to joining Houston Methodist Hospital. He has served as an ad hoc reviewer for the journals of Circulation, American Journal of Pathology, ASAIO and the Journal of Heart and Lung Transplantation. Dr. Youker’s primary focus has been in heart failure with a particular interest in inflammation and its role in the progression of heart failure. Dr. Youker prefers a hands-on approach in the laboratory and is expert in many areas from electron microscopy to molecular biology techniques and has earned a reputation of excellence in cardiovascular immunopathology research.

Description of Research

Dr. Youker focuses on research of the immune system in heart failure and metabolism in heart failure.

Areas Of Expertise

Immunology Cardiac Transplantation LVAD Heart Failure
Education & Training

, Baylor College of Medicine
Publications

MicroRNA-126 overexpression rescues diabetes-induced impairment in efferocytosis of apoptotic cardiomyocytes
Suresh Babu, S, Thandavarayan, RA, Joladarashi, D, Jeyabal, P, Krishnamurthy, S, Bhimaraj, A, Youker, KA & Krishnamurthy, P 2016, Scientific Reports, vol 6, 36207. DOI:

Macrophage bone morphogenic protein receptor 2 depletion in idiopathic pulmonary fibrosis and Group III pulmonary hypertension
Chen, NY, Collum, SD, Luo, F, Weng, T, Le, TT, Hernandez, AM, Philip, K, Molina, JG, Garcia-Morales, LJ, Cao, Y, Ko, TC, Amione-Guerra, J, Al-Jabbari, O, Bunge, RR, Youker, K, Bruckner, BA, Hamid, R, Davies, J, Sinha, N & Karmouty-Quintana, H 2016, American Journal of Physiology - Lung Cellular and Molecular Physiology, vol 311, no. 2, pp. 238-254. DOI:

Polymer based nanotherapeutics prevent the progression of pulmonary hypertension in a rat model
Youker, K 2016, International Society of Heart lung Transplantation , United States, 4/27/16 - 4/30/16, pp. s173-s174.

MicroRNA-9 inhibits hyperglycemia-induced pyroptosis in human ventricular cardiomyocytes by targeting ELAVL1
Jeyabal, P, Thandavarayan, RA, Joladarashi, D, Suresh Babu, S, Krishnamurthy, S, Bhimaraj, A, Youker, KA, Kishore, R & Krishnamurthy, P 2016, Biochemical and Biophysical Research Communications, vol 471, no. 4, pp. 423-429. DOI:

Combination of angiotensin II and l-NG-nitroarginine methyl ester exacerbates mitochondrial dysfunction and oxidative stress to cause heart failure
Hamilton, DJ, Zhang, A, Li, S, Cao, TN, Smith, JA, Vedula, I, Cordero-Reyes, AM, Youker, KA, Torre-Amione, G & Gupte, AA 2016, American Journal of Physiology - Heart and Circulatory Physiology, vol 310, no. 6, pp. H667-H680.

Rnd3/RhoE Modulates Hypoxia-Inducible Factor 1a/Vascular Endothelial Growth Factor Signaling by Stabilizing Hypoxia-Inducible Factor 1a and Regulates Responsive Cardiac Angiogenesis
Yue, X, Lin, X, Yang, T, Yang, X, Yi, X, Jiang, X, Li, X, Li, T, Guo, J, Dai, Y, Shi, J, Wei, L, Youker, KA, Torre-Amione, G, Yu, Y, Andrade, KC & Chang, J 2016, Hypertension, vol 67, no. 3, pp. 597-605. DOI:

Rnd3/RhoE Modulates Hypoxia-Inducible Factor 1a/Vascular Endothelial Growth Factor Signaling by Stabilizing Hypoxia-Inducible Factor 1a and Regulates Responsive Cardiac Angiogenesis
Yue, X, Lin, X, Yang, T, Yang, X, Yi, X, Jiang, X, Li, X, Li, T, Guo, J, Dai, Y, Shi, J, Wei, L, Youker, KA, Torre-Amione, G, Yu, Y, Andrade, KC & Chang, J 2016, Hypertension, vol 67, no. 3, pp. 597-605. DOI:

A specifically designed nanoconstruct associates, internalizes, traffics in cardiovascular cells, and accumulates in failing myocardium: A new strategy for heart failure diagnostics and therapeutics
Ruiz-Esparza, GU, Segura-Ibarra, V, Cordero-Reyes, AM, Youker, KA, Serda, RE, Cruz-Solbes, AS, Amione-Guerra, J, Yokoi, K, Kirui, DK, Cara, FE, Paez-Mayorga, J, Flores-Arredondo, JH, Guerrero-Beltrán, CE, Garcia-Rivas, G, Ferrari, M, Blanco, E & Torre-Amione, G 2016, European Journal of Heart Failure, vol 18, no. 2, pp. 169-178. DOI:

Combination of Angiotensin II and L-NG-Nitroarginine methyl ester exacerbates mitochondrial dysfunction and oxidative stress to cause heart failure
Hamilton, DJ, Zhang, A, Li, S, Cao, TN, Smith, JA, Vedula, I, Cordero-Reyes, AM, Youker, KA, Torre-Amione, G & Gupte, AA 2016, American Journal of Physiology - Heart and Circulatory Physiology, pp. ajpheart.00746.2015.

Combination of angiotensin II and l-NG-nitroarginine methyl ester exacerbates mitochondrial dysfunction and oxidative stress to cause heart failure
Hamilton, DJ, Zhang, A, Li, S, Cao, TN, Smith, JA, Vedula, I, Cordero-Reyes, AM, Youker, KA, Torre-Amione, G & Gupte, AA 2016, American Journal of Physiology - Heart and Circulatory Physiology, vol 310, no. 6, pp. H667-H680. DOI:

Full expression of cardiomyopathy is partly dependent on B-cells: A pathway that involves cytokine activation, immunoglobulin deposition, and activation of apoptosis
Cordero-Reyes, AM, Youker, KA, Trevino, AR, Celis, R, Hamilton, DJ, Flores-Arredondo, JH, Orrego, CM, Bhimaraj, A, Estep, JD & Torre-Amione, G 2016, Journal of the American Heart Association, vol 5, no. 1, pp. 1-12. DOI:

Rapamycin Polymer Nanotherapeutics for Pulmonary Hypertension Treatment
Segura-Ibarra, V, Amione-Guerra, J, Cruz-Solbes, AS, Torre, G, Youker, KA, Ashrith, G & Blanco, E 2016, American College of Cardiology (ACC) 2016, Chicago, United States, 4/2/16 - 4/4/16, .

Polymer Based Nanotherapeutics Prevent the Progression of Pulmonary Hypertension in a Rat Model
Segura-Ibarra, V, Amione-Guerra, J, Cruz-Solbes, AS, Youker, KA, Torre, G, Guha, A & Blanco, E 2016, The International Society for Heart & Lung Transplantation, Washington, DC, United States, 4/27/16 - 4/30/16, .

Temporal Assessment of Endothelial to Mesenchymal Transition as a Contributor to Fibrosis in a Mouse Model of Heart Failure
Youker, KA 2016, . DOI:

Vascular Reactivity Analysis in Patients with Continuous Flow Left Ventricular Assist Devices (CF-LVADs) - The Role of Endothelial Function in Continuous Flow Physiology
Youker, KA 2016, . DOI:

Presence of Endothelial to Mesenchymal Transition in End Stage Human Myocardial Samples-Documentation in Human Heart Failure for the First Time
Youker, KA 2016, . DOI:

Enhanced Cardiac Regenerative Ability of Stem Cells After Ischemia-Reperfusion Injury: Role of Human CD34(+) Cells Deficient in MicroRNA-377
Joladarashi, D, Srikanth Garikipati, VN, Thandavarayan, RA, Verma, SK, Mackie, AR, Khan, M, Gumpert, AM, Bhimaraj, A, Youker, KA, Uribe, C, Suresh Babu, S, Jeyabal, P, Kishore, R & Krishnamurthy, P 2015, Journal of the American College of Cardiology, vol 66, no. 20, pp. 2214-2226. DOI:

Standardized extracts from black bean coats (Phaseolus vulgaris L.) prevent adverse cardiac remodeling in a murine model of non-ischemic cardiomyopathy
García-Rivas, G, Youker, KA, Orrego, C, Flores-Arredondo, J, Guerrero-Beltrán, CE, Cordero-Reyes, A, Gutiérrez-Uribe, JA, García, M, Serna-Saldivar, SO & Torre-Amione, G 2015, RSC Advances, vol 5, no. 110, pp. 90858-90865. DOI:

Differential mitochondrial function in remodeled right and non-remodeled left ventricles in pulmonary hypertension.
Gupte, AA, Cordero-Reyes, AM, Youker, K, Matsunami, RK, Engler, DA, Loebe, M, Ashrith, G, Torre, G & Hamilton, DJ 2015, Journal of Cardiac Failure, pp. Epub.

Cardiac mitochondrial function in a non-ischemic mouse model of heart failure.
Gupte, AA, Cao, TN, Li, S, Zhang, A, Cordero-Reyes, AM, Youker, K, Torre, G & Hamilton, DJ 2015, Keystone symposia: Mitochondria, Metabolism and Heart Failure (J5), Santa Fe, United States, 1/27/15 - 2/1/15, .